Change Agents Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
CHGA
- Investments
-
8
- Share Price
-
$0.89
- (As of Monday Closing)
Change Agents General Information
Description
Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.
Contact Information
Website
www.ir.changeagentscorp.comCorporate Office
- 4400 Route 9 South
- Suite 3100
- Freehold, NJ 07728
- United States
Corporate Office
- 4400 Route 9 South
- Suite 3100
- Freehold, NJ 07728
- United States
Change Agents Timeline
Change Agents Stock Performance
As of 16-Nov-2026, Change Agents’s stock price is $0.89. Its current market cap is $1.12M with 1.25M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.89 | $1.07 | $0.69 - $37.65 | $1.12M | 1.25M | 690K | -$2.80 |
Change Agents Financials Summary
As of 30-Jun-2026, Change Agents has a trailing 12-month revenue of $350K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 30,969 | 24,643 | 31,258 | 33,074 |
| Revenue | 350 | 0 | 0 | 1,256 |
| EBITDA | (6,494) | (15,903) | (5,257) | (15,026) |
| Net Income | (8,979) | (18,261) | (7,903) | (16,707) |
| Total Assets | 14,721 | 23,401 | 20,985 | 20,583 |
| Total Debt | 1,335 | 940 | 2,124 | 8,506 |
Change Agents Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Change Agents Comparisons
Industry
Financing
Details
Change Agents Competitors (4)
One of Change Agents’s 4 competitors is Evox Therapeutics, a Venture Capital-Backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Evox Therapeutics | Venture Capital-Backed | Oxford, United Kingdom | ||||
| Quest Diagnostics | Corporation | Secaucus, NJ | ||||
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| Kimera Labs | Corporation | Miramar, FL |
Change Agents Patents
Change Agents Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220031836-A1 | Emulsomes comprising s-layer fusion proteins and methods of use thereof | Inactive | 03-Aug-2020 | ||
| WO-2022031376-A1 | Emulsomes comprising s-layer fusion proteins and methods of use thereof | Inactive | 03-Aug-2020 | ||
| US-20210403509-A1 | S-layer vaccine fusion proteins and methods of use | Inactive | 24-Jun-2020 | ||
| WO-2021262625-A1 | S-layer vaccine fusion proteins and methods of use | Inactive | 24-Jun-2020 | ||
| US-11401320-B2 | Qty fc fusion receptor proteins | Active | 31-Mar-2020 | C07K14/7158 |
Change Agents Signals
Change Agents Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Change Agents Investments & Acquisitions (8)
Change Agents’s most recent deal was a Merger/Acquisition with RPM Interactive for . The deal was made on 15-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RPM Interactive | 15-Dec-2025 | Merger/Acquisition | Multimedia and Design Software | ||
| Laboratory Services MSO | 09-Feb-2023 | Secondary Transaction - Private | Laboratory Services (Healthcare) | ||
| Hebei Senlangbio Biotechnology | 14-Jun-2021 | Merger/Acquisition | Drug Discovery | ||
| Cellular Immunotherapy (Arbele/Avalon GloboCare) | 23-Oct-2018 | Joint Venture | Drug Discovery | ||
| Epicon Biotech | 01-Sep-2018 | Joint Venture | Biotechnology |
Change Agents ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
37.86 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Change Agents Exits (1)
Change Agents’s most recent exit was on 15-Dec-2025 from RPM Interactive. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| RPM Interactive | 15-Dec-2025 | Completed |
|
Change Agents Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| RPM Interactive | New Brunswick, NJ | 2022 |
Change Agents FAQs
-
When was Change Agents founded?
Change Agents was founded in 2014.
-
Where is Change Agents headquartered?
Change Agents is headquartered in Freehold, NJ.
-
What is the size of Change Agents?
Change Agents has 2 total employees.
-
What industry is Change Agents in?
Change Agents’s primary industry is Biotechnology.
-
Is Change Agents a private or public company?
Change Agents is a Public company.
-
What is Change Agents’s stock symbol?
The ticker symbol for Change Agents is CHGA.
-
What is the current stock price of Change Agents?
As of 16-Nov-2026 the stock price of Change Agents is $0.89.
-
What is the current market cap of Change Agents?
The current market capitalization of Change Agents is $1.12M.
-
What is Change Agents’s current revenue?
The trailing twelve month revenue for Change Agents is $350K.
-
Who are Change Agents’s competitors?
Evox Therapeutics, Quest Diagnostics, Bio-Rad Laboratories, and Kimera Labs are competitors of Change Agents.
-
What is Change Agents’s annual earnings per share (EPS)?
Change Agents’s EPS for 12 months was -$2.80.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process